Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.48 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.48 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.48 |
| ▸ | NAAA | Q02083 | 1/20 | 0.46 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 4/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14499022 | 0.89 | TSHR (0.50) | TSHRADRB2ADRB1ADRB3NAAA | |
| SCHEMBL14443383 | 0.86 | ADRB2 (0.51) | ADRB2ADRB1ADRB3NAAANR4A2 | |
| SCHEMBL26692829 | 0.85 | TSHR (0.50) | TSHRNAAAKMT2ATDP1L3MBTL1 | |
| SCHEMBL17697791 | 0.85 | TSHR (0.50) | TSHRADRB2ADRB1ADRB3NAAA | |
| SCHEMBL21647504 | 0.83 | TSHR (0.48) | TSHRADRB2ADRB1ADRB3NAAA | |
| SCHEMBL22890912 | 0.83 | TSHR (0.48) | TSHRNAAAKMT2ATDP1L3MBTL1 | |
| SCHEMBL1594904 | 0.83 | TSHR (0.48) | TSHRADRB2ADRB1ADRB3NAAA | |
| SCHEMBL38655715 | 0.83 | TSHR (0.48) | TSHRADRB2ADRB1ADRB3NAAA | |
| SCHEMBL22890959 | 0.83 | NAAA (0.40) | TSHRADRB2ADRB1ADRB3NAAA | |
| SCHEMBL1991359 | 0.82 | TSHR (0.78) | TSHRNAAATDP1L3MBTL1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113568287-B | Photoresist cleaning agent for flexible panel and production process thereof | 江阴润玛电子材料股份有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-113568287-A | Photoresist cleaning agent for flexible panel and production process thereof | 江阴润玛电子材料股份有限公司 | 2021-10-29 | — | — | CN | claimed |
| WO-2024119099-A1 | GALLIUM-SALOPHEN ANTIMICROBIAL COMPOUNDS AND METHODS OF USE THEREOF | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2024-06-06 | — | — | WO | disclosed |
| EP-4272825-A2 | MTORC MODULATORS AND USES THEREOF | Aeovian Pharmaceuticals, Inc. (US) | 2023-11-08 | — | — | EP | disclosed |
| US-20230227476-A1 | GALLIUM-SALOPHEN ANTIMICROBIAL COMPOUNDS AND METHODS OF USE THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-07-20 | — | — | US | disclosed |
| US-20230227476-A1 | GALLIUM-SALOPHEN ANTIMICROBIAL COMPOUNDS AND METHODS OF USE THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-07-20 | — | — | US | disclosed |
| US-11702429-B2 | mTORC modulators and uses thereof | AEOVIAN PHARMACEUTICALS, INC. (US) | 2023-07-18 | — | — | US | disclosed |
| US-11702429-B2 | mTORC modulators and uses thereof | AEOVIAN PHARMACEUTICALS, INC. (US) | 2023-07-18 | — | — | US | disclosed |
| CN-113568287-B | Photoresist cleaning agent for flexible panel and production process thereof | 江阴润玛电子材料股份有限公司 | 2023-07-04 | — | — | CN | disclosed |
| CN-113568287-B | Photoresist cleaning agent for flexible panel and production process thereof | 江阴润玛电子材料股份有限公司 | 2023-07-04 | — | — | CN | disclosed |
| US-20230063462-A1 | SULFONIMIDAMIDE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS AG (CH) | 2023-03-02 | — | — | US | disclosed |
| CN-113568287-A | Photoresist cleaning agent for flexible panel and production process thereof | 江阴润玛电子材料股份有限公司 | 2021-10-29 | — | — | CN | disclosed |
| CN-113568287-A | Photoresist cleaning agent for flexible panel and production process thereof | 江阴润玛电子材料股份有限公司 | 2021-10-29 | — | — | CN | disclosed |
| US-11021492-B2 | mTORC modulators and uses thereof | AEOVIAN PHARMACEUTICALS, INC. (US) | 2021-06-01 | — | — | US | disclosed |
| US-20210032221-A1 | 1,2,3-TRIAZOLE INHIBITORS OF P97 AAA ATPASE ACTIVITY | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2021-02-04 | — | — | US | disclosed |
| US-20210008041-A1 | MTORC MODULATORS AND USES THEREOF | AEOVIAN PHARMACEUTICALS, INC. | 2021-01-14 | — | — | US | disclosed |
| US-20210002300-A1 | MTORC MODULATORS AND USES THEREOF | AEOVIAN PHARMACEUTICALS, INC. | 2021-01-07 | — | — | US | disclosed |
| WO-2020154447-A1 | MTORC MODULATORS AND USES THEREOF | AEOVIAN PHARMACEUTICALS, INC. (US) | 2020-07-30 | — | — | WO | disclosed |
| WO-2020102574-A1 | THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS INFLAMMASOME RESEARCH, INC. (US) | 2020-05-22 | — | — | WO | disclosed |
| WO-2010114978-A1 | RENIN INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2010-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702429-B2 | mTORC modulators and uses thereof | MTOR, RICTOR, RPTOR | TSHR 3270/4885ADRB2 4712/4885ADRB1 4673/4885 |
| US-20210008041-A1 | MTORC MODULATORS AND USES THEREOF | MTOR, RICTOR, RPTOR | TSHR 3270/4885ADRB2 4712/4885ADRB1 4673/4885 |
| US-20230063462-A1 | SULFONIMIDAMIDE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NLRP1, NLRP3, NOD1 | TSHR 4605/4885ADRB2 4249/4885ADRB1 3892/4885 |
| US-20210002300-A1 | MTORC MODULATORS AND USES THEREOF | MTOR, RICTOR, RPTOR | TSHR 3270/4885ADRB2 4712/4885ADRB1 4673/4885 |
| US-20210032221-A1 | 1,2,3-TRIAZOLE INHIBITORS OF P97 AAA ATPASE ACTIVITY | ATAD3B, ATAD3A, PSMG3 | TSHR 4782/4885ADRB2 3857/4885ADRB1 2806/4885 |
| US-20230227476-A1 | GALLIUM-SALOPHEN ANTIMICROBIAL COMPOUNDS AND METHODS OF USE THEREOF | SLC30A5, SALL4, GLB1 | TSHR 2817/4885ADRB2 2620/4885ADRB1 3113/4885 |
| US-11021492-B2 | mTORC modulators and uses thereof | MTOR, RICTOR, RPTOR | TSHR 3270/4885ADRB2 4712/4885ADRB1 4673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.